Abstract 10: Interaction between obesity and variants in angiogenesis-related genes and prostate cancer aggressiveness.
Ernest K. Amankwah(Johns Hopkins University), Jong Kook Park(Hallym University), Julio M. Pow‐Sang(Moffitt Cancer Center), Ya-Yu Tsai(Moffitt Cancer Center), Selina Radlein(Moffitt Cancer Center), Hyun Park(Korea University), Xiaotao Qu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Thomas A. Sellers(Mayo Clinic), Ardeshir Hakam(Roche (Switzerland)), Hui‐Yi Lin(Moffitt Cancer Center)
Cited by 1
Related Papers
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
|The Lancet Oncology|2017|1.8k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
|Journal of Clinical Oncology|2020|1.3k
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
|PLoS ONE|2015|906
Prostate Cancer, Version 1.2016
|Journal of the National Comprehensive Cancer Network|2016|656